Noradrenergic modulation of ephedrine-induced hypophagia

Synapse

Volumn 48, Issue 1, 2003, Pages 18-24

  Wellman, Paul J ^a   Miller, Dennis K ^a   Ho, Dao H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

1 adrenoceptors; Drinking; Feeding; Prazosin; Rats; Sympathomimetic drugs

Indexed keywords

AMINOREX; AMPHETAMINE; EPHEDRINE; MAZINDOL; NORADRENALIN; PHENTERMINE; PRAZOSIN; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRINKING BEHAVIOR; DRUG EFFECT; DRUG POTENCY; FEEDING BEHAVIOR; FOOD INTAKE; HYPOPHAGIA; MALE; NONHUMAN; NORADRENERGIC SYSTEM; OBESITY; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; WEIGHT REDUCTION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; EATING DISORDERS; EPHEDRINE; MALE; NOREPINEPHRINE; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; REGRESSION ANALYSIS;

EID: 0037399621     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10182     Document Type: Article

References (47)

1. Angrist B, Rotrosen J, Kleinberg D, Merriam V, Gershon S. 1977. Dopaminergic agonist properties of ephedrine-theoretical implications. Psychopharmacology 1955:115-120.
2. Arch JR, Ainsworth AT, Cawthorne MA. 1982. Thermogenic and anorectic effects of ephedrine and congeners in mice and rats. Life Sci 30:1817-1826.
3. Astrup A, Breum L, Toubro S. 1995. Pharmacological and clinical studies of ephedrine and other thermogenic agonists. Obesity Res 3:537S-540S.
4. Berretta N, Bernardi G, Mercuri NB. 2000. Alpha1-adrenoceptor-mediated excitation of substantia nigra pars reticulataneurons. Neuroscience 98:599-604.
5. Blandini F, Joseph SA, Tassorelli C. 1997. Systemic administration of ephedrine induces Fos protein expression in caudate putamen and subthalamic nucleus of rats. Funct Neurol 12:293-296.
6. Blosser JC, Barrantes M, Parker RB. 1987. Correlation between anorectic potency and affinity for hypothalamic (+)-amphetamine binding sites of phenylethylamines. Eur J Pharmacol 134:97-103.
7. Bray GA. 1999. Drug treatment of obesity. Best Pract Res Clin Endocr Metab 13:131-48.
8. Bray, GA. 2000. A concise review of the therapeutics of obesity. Nutrition 16:953-960.
9. Camargo LA, Saad WA. 2001. Role of the alpha(1)- and alpha(2)-adrenoceptors of the paraventricular nucleus on the water and salt intake, renal excretion, and arterial pressure induced by angiotension II injection into the medial septal area. Brain Res Bull 54:595-602.
10. Cambridge D, Davey MJ, Massingham R. 1977. Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors. Br J Pharmacol 59:514P-515P.
11. Chait LD. 1994. Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 113:381-387.
12. Corbit JD, Stellar E. 1964. Palatability, food intake and obesity in normal and hyperphagic rats. J Comp Physiol Psychol 58:63-67.
13. Davies BT, Wellman PJ 1992. Effects on ingestive behavior in rats of the alpha1-adrenoceptor agonist cirazoline. Eur J Pharmacol 210: 11-16.
14. 1-agonist methoxamine into the paraventricular hypothalamus induces hypophagia in rats. Brain Res Bull 28:633-635.
15. Fairchild MD, Alles GA. 1967. The central locomotor stimulatory activity and acute toxicity of the ephedrine and norephedrine isomers in mice. J Pharmacol Exp Ther 158:135-139.
16. Fox AW, Abel PW, Minneman KP. 1985. Activation of α 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery. Eur J Pharmacol 116:145-152.
17. Grenhoff J, Svensson TH. 1993. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79-84.
18. Gruber AJ, Pope HGJ. 1988. Ephedrine abuse among 36 female weightlifters. Am J Addict 7:256-261.
19. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ. 1997. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 121:1613-1618.
20. Kanayama G, Gruber AJ, Pope HG, Borowiecki JJ, Hudson JI. 2001. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom 70:137-140.
21. Kawasuji T, Koike K, Saito H. 1996. Chronotropic effects of optical isomers of ephedrine and methylephedrine in the isolated rat right atria and in vitro assessment of direct and indirect actions on β 1-adrenoceptors. Biolog Pharmacol Bull 19:1423-1428.
22. Leibowitz SF. 1975. Amphetamine: possible site and mode of action for producing anorexia in the rat. Brain Res 84:160-167.
23. Leibowitz SF, Rossakis C. 1979. Pharmacological characterization of perifornical hypothalamic dopamine receptors mediating feeding inhibition in the rat. Brain Res 172:115-130.
24. Malchow-Moller A, Larsen S, Hey H, Stokholm KH, Juhl E, Quaade F. 1981. Ephedrine as an anorectic: the story of the 'Elsinore pill.' Int J Obes 5:183-187.
25. Martin WR, Sloan JW, Sapira JD, Jasinski DR. 1971. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258.
26. Miller DK, Nation JR, Wellman PJ. 1999. Sensitization of anorexia and locomotion induced by chronic administration of ephedrine in rats. Life Sci 65:501-511.
27. Minneman KP, Fox AW, Abel PW. 1983. Occupancy of α 1-adrenergic receptors and contraction of rat vas deferens. Mol Pharmacol 23: 359-368.
28. Mitchell JC, Jackson HC, Heal DJ. 1998. Effects of monoamine antagonists on aminorex, phentermine and d-amphetamine hypophagia. J Psychopharmacol 12, A38.
29. Morien A, McMahon L, Wellman PJ. 1993. Effects on food and water intake of the α1-adrenoceptor agonists amidephrine and SK&F89748. Life Sci 53:169-174.
30. Richelson, E., Souder, T. 2000. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68:29-39.
31. Rokosh DG, Bailey BA, Stewart AF, Karns LR, Long CS, Simpson PC. 1994. Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D. Biochem Biophys Res Comm 200:1177-1184.
32. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS. 2001. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32-41.
33. Ruwe WD, Naylor AM, Bauce L, Veale WL. 1985. Determination of the endogenous and evoked release of catecholamines from the hypothalamus and caudate nucleus of the conscious and unrestrained rat. Life Sci 37:1749-1756.
34. Schnabel KH, Shatz V, Busch S, Just H. 1976. Drug-induced primary vascular pulmonary hypertension. Med Welt 27:1300-1303.
35. Shannon HE, Degregorio CM. 1982. Self-administration of the endogenous trace amines beta-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs. J Pharmacol Exp Ther 222:52-60.
36. Tinsley JA, Watkins DD. 1998. Over-the-counter stimulants-abuse and addiction. Mayo Clinic Proc 73:977-982.
37. Walker RB, Fitz LD, Williams LM, Linton HJ, Smith CC. 1993. The effect of ephedrine isomers and their oxazolidines on locomotor activity in rats. Gen Pharmacol 24:669-673.
38. Wellman PJ. 2000. Norepinephrine and the control of food intake. Nutrition 16:837-842.
39. Wellman PJ, Davies BT. 1990. Effects of paraventricular hypothalamic microinjections of phenylpropanolamine and d-amphetamine on mash intake in rats. Brain Res Bull 25:335-338.
40. Wellman PJ, Davies BT. 1991. Suppression of feeding induced by phenylephrine microinjections within the paraventricular hypothalamus in rats. Appetite 17:121-128.
41. Wellman PJ, Davies BT. 1992. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the α 1-receptor antagonist prazosin. Pharmacol Biochem Behav 42:97-100.
42. Wellman PJ, Davies, BT, Morien A, McMahon, L. 1993a. Modulation of feeding by hypothalamic paraventricular nucleus α1- and α2-adrenergic receptors. Life Sci 53:669-679.
43. Wellman PJ, DiCarlo B, Morien A, Davies BT. 1993b. Effects of intra-PVN injections of d- and 1-norephedrine on feeding in rats. Brain Res Bull 32:443-445.
44. Wellman PJ, Miller DK, Livermore CL, Green TA, McMahon LR, Nation JR. 1998. Effects of (-)-ephedrine on locomotion, feeding, and nucleus accumbens dopamine in rats. Psychopharmacology 135:133-140.
45. Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, Vimont RL, Chapple CR, Chess-Williams R, Eglen RM, Clarke DE, Ford AP. 1999. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists. Br J Pharmacol 127:252-258.
46. Zarrindast, MR. 1981. Dopamine-like properties of ephedrine in rat brain. Br J Pharmacol 74:119-122.
47. Zarrindast MR, Hosseini-Nia T, Farnoodi F. 1987. Anorectic effect of ephedrine. Gen Pharmacol 18:559-561.